DEBORAH ANNE SILBERMAN MD
Prescription History 1346352275
Ophthalmology in Brooklyn, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DEBORAH ANNE SILBERMAN MD, an active Ophthalmology specialist practicing in Brooklyn, NY. Our medical registry currently tracks 29 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 5,411 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 1,594 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Latanoprost | 1,594 | $22.37 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 1,594 Medicare prescriptions for Latanoprost, about 11 times the volume of the typical New York prescriber of this medication (149). Medicare paid an average of $22.37 per fill, versus $20.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 3,344.2 30-Day Fills standardized to 30-day supplies 98,232 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 645 | $26.17▼ below NY avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 645 Medicare prescriptions for Dorzolamide-Timolol, about 7.2 times the volume of the typical New York prescriber of this medication (90). Medicare paid an average of $26.17 per fill, versus $32.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 1,164.2 30-Day Fills standardized to 30-day supplies 34,832 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 505 | $50.13▼ below NY avg | ▲ More than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 505 Medicare prescriptions for Prednisolone Acetate, about 3.7 times the volume of the typical New York prescriber of this medication (135). Medicare paid an average of $50.13 per fill, versus $52.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 651.9 30-Day Fills standardized to 30-day supplies 18,741 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 437 | $32.15 | ▲ More than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 437 Medicare prescriptions for Ketorolac Tromethamine, about 4.4 times the volume of the typical New York prescriber of this medication (99). Medicare paid an average of $32.15 per fill, versus $26.57 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 733.6 30-Day Fills standardized to 30-day supplies 21,821 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 406 | $21.36 | ▲ More than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 406 Medicare prescriptions for Ofloxacin, about 5.6 times the volume of the typical New York prescriber of this medication (73). Medicare paid an average of $21.36 per fill, versus $20.90 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 487.4 30-Day Fills standardized to 30-day supplies 11,981 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 348 | $79.69 | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 348 Medicare prescriptions for Brimonidine Tartrate, about 5.7 times the volume of the typical New York prescriber of this medication (61). Medicare paid an average of $79.69 per fill, versus $70.70 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 690.3 30-Day Fills standardized to 30-day supplies 20,482 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 329 | $54.96 | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 329 Medicare prescriptions for Timolol Maleate, about 4.7 times the volume of the typical New York prescriber of this medication (70). Medicare paid an average of $54.96 per fill, versus $38.85 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 692.2 30-Day Fills standardized to 30-day supplies 20,676 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 226 | $684.84 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 226 Medicare prescriptions for Lumigan, about 2.9 times the volume of the typical New York prescriber of this medication (77). Medicare paid an average of $684.84 per fill, versus $492.27 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 526.4 30-Day Fills standardized to 30-day supplies 15,662 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 147 | $23.30▼ below NY avg | ▲ More than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 147 Medicare prescriptions for Dorzolamide Hcl, about 3.1 times the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $23.30 per fill, versus $30.75 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 282.5 30-Day Fills standardized to 30-day supplies 8,471 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 125 | $489.58 | ▲ More than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 125 Medicare prescriptions for Alphagan P, about 2.6 times the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $489.58 per fill, versus $396.46 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 254.6 30-Day Fills standardized to 30-day supplies 7,481 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 83 | $608.43 | ▲ More than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 83 Medicare prescriptions for Rhopressa, about 1.7 times the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $608.43 per fill, versus $467.97 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 142.5 30-Day Fills standardized to 30-day supplies 4,081 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 81 | $487.27 | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 81 Medicare prescriptions for Combigan, about 1.6 times the volume of the typical New York prescriber of this medication (52). Medicare paid an average of $487.27 per fill, versus $403.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 153.9 30-Day Fills standardized to 30-day supplies 4,520 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 81 | $304.81▼ below NY avg | ▲ More than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 81 Medicare prescriptions for Brinzolamide, about 2.6 times the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $304.81 per fill, versus $343.65 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 182 30-Day Fills standardized to 30-day supplies 5,458 Days of Medication total across all patients in 2023 | |||
| Travoprost | 57 | $371.77 | ▲ More than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 57 Medicare prescriptions for Travoprost, about 1.6 times the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $371.77 per fill, versus $266.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 125.9 30-Day Fills standardized to 30-day supplies 3,732 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 46 | $271.86 | ▲ More than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 46 Medicare prescriptions for Simbrinza, about 1.4 times the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $271.86 per fill, versus $261.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 65.6 30-Day Fills standardized to 30-day supplies 1,955 Days of Medication total across all patients in 2023 | |||
| Azelastine Hcl | 38 | $42.55 | ≈ Typical |
About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾ Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms. In 2023, this provider wrote 38 Medicare prescriptions for Azelastine Hcl, about 79% of the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $42.55 per fill, versus $34.26 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 52 30-Day Fills standardized to 30-day supplies 1,536 Days of Medication total across all patients in 2023 | |||
| ProlensaBromfenac Sodium | 37 | $536.26 | ▼ Less than typical |
About Prolensa: This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Show more ▾ Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. In 2023, this provider wrote 37 Medicare prescriptions for Prolensa, about half the volume of the typical New York prescriber of this medication (70). Medicare paid an average of $536.26 per fill, versus $355.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 59.6 30-Day Fills standardized to 30-day supplies 1,756 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 31 | $314.87 | ▲ More than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 31 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 1.3 times the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $314.87 per fill, versus $303.99 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 67.1 30-Day Fills standardized to 30-day supplies 1,983 Days of Medication total across all patients in 2023 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 25 | $72.08▼ below NY avg | ▼ Less than typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye. In 2023, this provider wrote 25 Medicare prescriptions for Tobramycin-Dexamethasone, about 61% of the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $72.08 per fill, versus $81.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 26.3 30-Day Fills standardized to 30-day supplies 446 Days of Medication total across all patients in 2023 | |||
| AzoptBrinzolamide | 25 | $450.74▼ below NY avg | ≈ Typical |
About Azopt: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 25 Medicare prescriptions for Azopt, about 89% of the volume of the typical New York prescriber of this medication (28). Medicare paid an average of $450.74 per fill, versus $476.36 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 43.5 30-Day Fills standardized to 30-day supplies 1,305 Days of Medication total across all patients in 2023 | |||
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 24 | $8.13▼ below NY avg | ▼ Less than typical |
About Polymyxin B Sul-Trimethoprim: This medication is used to treat bacterial infections (such as blepharitis, conjunctivitis) of the eye. Show more ▾ It contains 2 antibiotics. Polymyxin B works by killing the bacteria. Trimethoprim works by stopping the growth of the bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 24 Medicare prescriptions for Polymyxin B Sul-Trimethoprim, about 65% of the volume of the typical New York prescriber of this medication (37). Medicare paid an average of $8.13 per fill, versus $8.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 24.9 30-Day Fills standardized to 30-day supplies 551 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 21 | $662.50 | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 21 Medicare prescriptions for Vyzulta, about half the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $662.50 per fill, versus $412.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43.1 30-Day Fills standardized to 30-day supplies 1,268 Days of Medication total across all patients in 2023 | |||
| Olopatadine Hcl | 18 | $24.79▼ below NY avg | ▼ Less than typical |
About Olopatadine Hcl: This medication is an antihistamine used to treat itching and redness in the eyes due to allergies. Show more ▾ This medication is not recommended for the treatment of eye irritation due to wearing contact lenses. In 2023, this provider wrote 18 Medicare prescriptions for Olopatadine Hcl, about a third of the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $24.79 per fill, versus $43.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 25.4 30-Day Fills standardized to 30-day supplies 715 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 16 | $1,312.85 | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 16 Medicare prescriptions for Restasis, about 17% of the volume of the typical New York prescriber of this medication (93). Medicare paid an average of $1,312.85 per fill, versus $1,034.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2023 | |||
| Pilocarpine Hcl | 16 | $104.76 | ▼ Less than typical |
About Pilocarpine Hcl: This medication is used to treat symptoms of dry mouth due to a certain immune disease (Sjogren's syndrome) or from saliva gland damage due to radiation treatments of the head/neck for cancer. Show more ▾ Pilocarpine belongs to a class of drugs known as cholinergic agonists. It works by stimulating certain nerves to increase the amount of saliva you produce, making it easier and more comfortable to speak and swallow. A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. In 2023, this provider wrote 16 Medicare prescriptions for Pilocarpine Hcl, about half the volume of the typical New York prescriber of this medication (32). Medicare paid an average of $104.76 per fill, versus $82.18 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49.7 30-Day Fills standardized to 30-day supplies 1,490 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 15 | $852.16 | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 15 Medicare prescriptions for Rocklatan, about a third of the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $852.16 per fill, versus $517.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29.5 30-Day Fills standardized to 30-day supplies 845 Days of Medication total across all patients in 2023 | |||
| Acetazolamide | 13 | $105.83 | ▼ Less than typical |
About Acetazolamide: Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. Show more ▾ This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures). One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) In 2023, this provider wrote 13 Medicare prescriptions for Acetazolamide, about half the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $105.83 per fill, versus $76.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Epinastine Hcl | 11 | $53.53▼ below NY avg | ▼ Less than typical |
About Epinastine Hcl: This medication is an antihistamine used to prevent itching of the eyes caused by allergies (allergic conjunctivitis). In 2023, this provider wrote 11 Medicare prescriptions for Epinastine Hcl, about half the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $53.53 per fill, versus $77.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 14.2 30-Day Fills standardized to 30-day supplies 427 Days of Medication total across all patients in 2023 | |||
| Bepotastine Besilate | 11 | $214.09▼ below NY avg | ▼ Less than typical |
About Bepotastine Besilate: This medication is used to treat itching of the eyes due to allergies. Show more ▾ Bepotastine is an antihistamine. It works by blocking a certain natural substance (histamine) that causes allergic symptoms. Do not use this medication to treat red or irritated eyes due to wearing contact lenses. Contact your doctor for further instructions if this occurs. In 2023, this provider wrote 11 Medicare prescriptions for Bepotastine Besilate, about 11% of the volume of the typical New York prescriber of this medication (98). Medicare paid an average of $214.09 per fill, versus $247.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 11.7 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DEBORAH ANNE SILBERMAN MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Brooklyn, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
